Keros Therapeutics (KROS) Receivables (2021 - 2025)
Keros Therapeutics (KROS) reported Receivables of $3.6 million for Q4 2025, up 30.09% on a YoY basis from $2.7 million in Q4 2024, and up 2.15% quarter-over-quarter from $3.5 million in Q3 2025.
Keros Therapeutics (KROS) Receivables (2021 - 2025) Analysis & Trends
Keros Therapeutics has reported Receivables for 4 years, with the latest figure at $3.6 million in Q4 2025.
- For the quarter ending Q4 2025, Receivables rose 30.09% year-over-year to $3.6 million; the trailing twelve-month figure through Dec 2025 stood at $3.6 million (up 30.09% YoY), and the FY2025 full-year result was $3.6 million, up 30.09% from the prior year.
- Receivables for Q4 2025 stood at $3.6 million, up from $3.5 million in the prior quarter.
- The five-year high for Receivables was $18.0 million in Q4 2021, with the low at $4000.0 in Q2 2024.
- Historically, Receivables has averaged $5.6 million across 4 years, with a median of $2.7 million in 2024.
- The largest YoY upside for Receivables was 395300.0% in 2025 against a maximum downside of 30.09% in 2025.
- Keros Therapeutics' Receivables stood at $18.0 million in 2021, then slumped by 99.21% to $143000.0 in 2023, then jumped by 1817.48% to $2.7 million in 2024, then soared by 30.09% to $3.6 million in 2025.
- The last three Receivables figures came in at $3.6 million (Q4 2025), $3.5 million (Q3 2025), and $15.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Keros Therapeutics | 399.01 Mn | 111.61 Mn | - | 3.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.57 Mn |
| Sep 30, 2025 | 3.49 Mn |
| Jun 30, 2025 | 15.82 Mn |
| Mar 31, 2025 | 17.29 Mn |
| Dec 31, 2024 | 2.74 Mn |
| Sep 30, 2024 | 388,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Mar 31, 2024 | 226,000.00 |
| Dec 31, 2023 | 143,000.00 |
| Dec 31, 2021 | 18.00 Mn |
| Jun 30, 2021 | 200,000.00 |